Yuanta Securities Korea Co., Ltd. (KRX:003470)

Market Cap	722.43B
Revenue (ttm)	2.24T
Net Income (ttm)	40.50B
Shares Out	205.49M
EPS (ttm)	197.66
PE Ratio	17.76
Forward PE	n/a
Dividend	200.00 (5.65%)
Ex-Dividend Date	Mar 28, 2025

Volume	251,423
Average Volume	552,398
Open	3,540.00
Previous Close	3,540.00
Day's Range	3,495.00 - 3,615.00
52-Week Range	2,465.00 - 4,605.00
Beta	0.99
RSI	39.58
Earnings Date	Aug 14, 2025

About Revance Therapeutics

Yuanta Securities Korea Co., Ltd. provides various financial services in South Korea and internationally. The company offers various investment banking services for stock, stock-related bonds, paid-in capital increase, IPO, M&A, PE, etc.; and specialized services for stocks, bonds, profitable securities, stock-related securities, trust, wrap a count, bancassurance, retirement pension, etc., as well as asset management services. It also provides stock corporate business customized services, such as trend of stock and derived market; information ...

• Industry: Capital Markets
• Sector: Financials
• Founded: 1962
• Employees: 1,722
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003470

Financial Performance

In 2024, Yuanta Securities Korea's revenue was 2.19 trillion, a decrease of -8.40% compared to the previous year's 2.39 trillion. Earnings were 65.49 billion, an increase of 1.65%.